Podcasts about healthtech

In this episode of the Smarter Not Harder Podcast, the HOMeHOPe Faculty gathers for a bold and visionary roundtable on the future of integrative health technologies — imagined, invented, or yet to be built. From nervous system shields to microbiome translators and Star Trek-style diagnostics, this conversation challenges the limits of what healing tools could (and should) be. Join us as we delve into: A device that dynamically balances your autonomic nervous system How your gut microbes might one day talk back to you Regenerative mineral cocktails inspired by frog-limb science Holodecks for healing: using environment as medicine This episode is for you if: You're excited by the intersection of sci-fi and health optimization You've ever wished your nervous system had an “off” button You're fascinated by the microbiome, metabolomics, or mind-body tech You want to explore healing beyond pills, protocols, and gadgets You can also find this episode on… YouTube: https://youtu.be/ceaTdYELEzM Find more from Smarter Not Harder: Website: https://troscriptions.com/blogs/podcast Instagram: https://instagram.com/troscriptions/ HOMeHOPe Symposium: https://homehope.org/homehope-symposium Get 10% Off your purchase of the Metabolomics Module by using PODCAST10 at https://www.homehope.org Get 10% Off your Troscriptions order with code POD10 at https://www.troscriptions.com Get daily content from the hosts of Smarter Not Harder by following @troscriptions on Instagram..

Episode 65 - Igor Araújo is a Brazilian professional mixed martial artist. A professional competitor since 2004, Igor has competed for the UFC, M-1 Global, Shooto, KSW and was a contestant on The Ultimate Fighter. Disclaimer: Please note that all information and content on the UK Health Radio Network, all its radio broadcasts and podcasts are provided by the authors, producers, presenters and companies themselves and is only intended as additional information to your general knowledge. As a service to our listeners/readers our programs/content are for general information and entertainment only.  The UK Health Radio Network does not recommend, endorse, or object to the views, products or topics expressed or discussed by show hosts or their guests, authors and interviewees.  We suggest you always consult with your own professional – personal, medical, financial or legal advisor. So please do not delay or disregard any professional – personal, medical, financial or legal advice received due to something you have heard or read on the UK Health Radio Network.

You don't have to spend hundreds of dollars doing a DEXA Scan or InBody to know how much lean muscle mass you have...or your body fat percentage. Spren does it through an incredible app that is AS ACCURATE as DEXA.  Watch on Youtube Follow me on Instagram My coaching client testimonials Website Chapters 00:00 Introduction to Biohacking and Body Composition 04:28 The Evolution of Elite HRV to Spren 08:42 Understanding Body Metrics and Their Importance 13:19 Exploring the Android-Gynoid Ratio 17:38 Lean Mass Index and Personal Health Journeys 20:38 Understanding Body Types and Their Implications 26:57 Personalized Nutrition Plans 35:30 The Philosophy Behind Spren 36:31 Balancing Complexity and Simplicity in Health Tech 42:15 The Role of AI in Personal Coaching 44:04 The Role of AI in Personal Health Tracking 48:37 Enhancing Accountability with AI Coaching 52:19 Understanding Body Composition and Its Importance 58:18 The Future of Health Monitoring Technology 01:03:09 Accessibility and Affordability in Health Tech  

Happy Q4 Heart of Healthcare Listeners! We're back with your monthly Digital Health Download, where we discuss the biggest industry headlines of the month. We cover:

In this episode of The Digital Executive, host Brian Thomas welcomes Dr. Masoud Nafey, a three-time AI founder, senior consultant, and board member with deep roots in health tech and human-centered innovation. From his family's journey as refugees from Afghanistan to becoming a Silicon Valley entrepreneur, Dr. Nafey shares how resilience and a passion for impact have shaped his work.He discusses the differences between scaling startups and driving innovation inside large enterprises, highlighting both the challenges and advantages of each. Dr. Nafey also introduces MENT, his AI-driven, privacy-first app designed to empower professionals with authentic, meaningful connections—built with privacy by design at its core.Looking ahead, he explores how AI can transform healthcare by easing the administrative burdens on physicians, enabling them to focus on empathy, care, and patient outcomes. Dr. Nafey's vision is clear: harness technology to strengthen—not replace—human connection.If you liked what you heard today, please leave us a review - Apple or Spotify. See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

In this episode, Dr. Karen Litzy speaks with Steve Lewis, founder of Nabu, about the importance of empowering patients through technology. Steve shares his personal journey from working with musicians to developing a health tech startup aimed at improving patient care. The conversation explores the challenges of creating a health tech product, the importance of communication in healthcare, and the future of patient advocacy. Steve emphasizes the need for comprehensive tools that help patients manage their health information and advocate effectively for themselves.   Takeaways ·      His daughter's health challenges inspired Steve's journey into health tech. ·      Naboo aims to provide a single source of truth for patient information. ·      Effective communication is crucial for patient care and adherence. ·      Building a health tech startup requires understanding the needs of all stakeholders. ·      Safety and compliance are paramount in developing health tech solutions. ·      Patients need tools that help them advocate for their own care. ·      The entrepreneurial journey involves collaboration and community support. ·      Technology can enhance the patient experience and improve outcomes. ·      Don't hesitate to share your ideas and seek feedback. ·      Financial literacy is essential for aspiring entrepreneurs.   Time Stamps:  00:00 Introduction to Patient Empowerment 03:11 The Journey from Music to Medicine 05:55 The Birth of Nabu: A New Tool for Patients 08:42 Building a Health Tech Startup 12:01 Navigating Challenges in Health Tech 14:50 The Importance of Communication in Healthcare 17:57 Enhancing Patient Care with Technology 20:42 Safety and Compliance in Patient Care 23:49 His daughter's Experience with Nabu 26:52 The Future of Patient Advocacy 29:41 Entrepreneurial Insights and Advice   More About Steve:Steve Lewis is an internationally recognised healthtech founder, product leader, and patient advocate, known for building breakthrough solutions at the intersection of technology and real-world care. As Founder and CEO of Nabu.ai, Steve is on a mission to transform fragmented health information into a single, actionable source of truth for patients, families, and care teams. With over 20 years of experience spanning creative, brand strategy, product design, digital transformation, and startup leadership, Steve's work is informed by both professional expertise and deeply personal experience. His daughter's early arrival in the NICU and complicated health journey catalysed his relentless pursuit to fix the fragmented care journey as an advocate, an insight that powers Nabu's vision for a truly comprehensive patient- and carer-led technology addressing the most critical problems in health. Steve is rapidly emerging as a sought-after voice in digital health and innovation. He has been invited to share his authentic, “from the front lines” perspective at live events and on leading digital health podcasts. Steve's talks explore themes including AI for health equity, patient empowerment, data privacy, and the future of connected care, resonating with audiences for their candor and real-world relevance. A passionate believer in co-design and inclusion, Steve is actively collaborating with Australia's leading healthcare providers to validate the Nabu Advocate platform and drive innovation in its core feature set. By working closely with clinicians, families, special needs communities, and expert advisory boards, Steve ensures Nabu is built to meet real-world needs and deliver meaningful impact. Steve's story, which is rooted in resilience, empathy, and systems change resonates with audiences from hospital executives to grassroots advocates. Whether on stage, on air, or in the boardroom, he is known for challenging the status quo and inspiring others to put patient voices at the centre of healthcare transformation. Resources from this Episode: Nabu Website Steve on LinkedIn   Jane Sponsorship Information: Book a one-on-one demo here Mention the code LITZY1MO for a free month   Follow Dr. Karen Litzy on Social Media: Karen's Instagram Karen's LinkedIn   Subscribe to Healthy, Wealthy & Smart: YouTube Website Apple Podcast Spotify SoundCloud Stitcher iHeart Radio

The future of learning isn’t static — it’s responsive, reflective, and built for capability. In this follow-up to our first AI episode, Zoe, Michelle, and Ausmed CEO Will Egan explore the next phase of AI in learning: generative learning — and the governance frameworks that make it safe and useful in real-world healthcare settings. From rubrics and role-based prompts to closed systems and guardrails, this episode takes a look into how generative AI can personalise learning, support performance, and finally help us bridge the gap between theory and practice. Contact the show at podcast@ausmed.com.au Follow Ausmed on LinkedIn, Facebook & Instagram Resources: AI and Privacy | Guide AI Bias and Cultural Safety in Aged Care | Guide Using AI in Healthcare Education | Guide How AI and Machine Learning Is Impacting Nursing | Guide What does AI mean for healthcare in Australia? | Guide Why Reflection Matters | Guide Thinking Differently About Change (Pt. 1) | Thought Leadership Smart Strategies for Healthcare Education | Thought Leadership Learn More About Ausmed: https://lnk.bio/ausmed/organisationsSee omnystudio.com/listener for privacy information.

In this episode of Medsider Radio, we sat down with Josh Vose, CEO of Tulavi Therapeutics.Tulavi is advancing hydrogel-based implants like the allay Hydrogel Cap, which is designed to optimize nerve injury recovery and reduce the risk of neuroma formation.Josh is a physician, engineer, and entrepreneur with more than 20 years of experience in medical devices. He has held leadership roles at Medtronic following its acquisition of PEAK Surgical and drove growth at startups including SIA Health, which he led through commercialization and acquisition by Integra LifeSciences.In this interview, Josh shares why defining the clinical problem with absolute clarity is the foundation of medtech success, and how leaning into the harder regulatory path can create lasting moats.Before we dive into the discussion, I wanted to mention a few things:First, if you're into learning from medical device and health technology founders and CEOs, and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.Second, if you want to peek behind the curtain of the world's most successful startups, you should consider a Medsider premium membership. You'll learn the strategies and tactics that founders and CEOs use to build and grow companies like Silk Road Medical, AliveCor, Shockwave Medical, and hundreds more!We recently introduced some fantastic additions exclusively for Medsider premium members, including playbooks, which are curated collections of our top Medsider interviews on key topics like capital fundraising and risk mitigation, and 3 packages that will help you make use of our database of 750+ life science investors more efficiently for your fundraise and help you discover your next medical device or health technology investor!In addition to the entire back catalog of Medsider interviews over the past decade, premium members also get a copy of every volume of Medsider Mentors at no additional cost, including the latest Medsider Mentors Volume VII. If you're interested, go to medsider.com/subscribe to learn more.Lastly, if you'd rather read than listen, here's a link to the full interview with Josh Vose.

Cancer drugs cost more than ever, yet survival benefits are often modest—and in some cases, patients can't even access the care that already exists. After losing his father, Steve Jobs, to pancreatic cancer, Reed Jobs committed himself to making this the last generation that loses parents to the disease.Reed now leads Yosemite, a venture fund spun out of Emerson Collective in 2023, alongside Investor Matt Bettonville. Yosemite pairs life sciences and digital health investments with a grantmaking model to accelerate cancer research and ensure breakthroughs actually reach patients.We cover:

In this episode, I'm joined by three exceptional members of our Healthtech Marketing Network - Mariana Small, Elena Putilina, and Amy Swanson - who spearheaded our first-ever AI Cohort project. Together, they surveyed over 100 healthtech marketing leaders to understand how our community is actually using AI in their day-to-day work, moving beyond the hype to examine practical applications and real challenges.The research revealed some fascinating insights about where we stand as an industry. While 93% of respondents are using AI in some capacity, very few organizations have successfully integrated AI into their core workflows or developed strategic roadmaps for implementation. Perhaps most telling, almost no one is measuring AI's impact beyond basic productivity metrics, creating a significant gap between leadership's enthusiasm and actual business value demonstration.While leadership teams are generally supportive and see potential value, they're looking for AI to drive demand generation and performance improvements - not just cost savings. However, marketers are struggling with workflow integration, tool selection overwhelm, and demonstrating clear ROI. The community has identified four key areas where they need help: AI-based search optimization, future skills development, creating repeatable workflows, and establishing governance frameworks.This research confirms we're still in the early stages of AI adoption in healthtech marketing, but it also provides a clear roadmap for moving from experimentation to strategic implementation. The findings show that while the enthusiasm is there, we need to focus on building proper foundations.Key Topics Covered"(00:00:00) Introduction""(00:01:00) Meet the AI Cohort Team""(00:05:00) State of AI Usage in Healthtech Marketing""(00:07:00) Most Popular AI Tools and Applications""(00:09:00) The Measurement Challenge""(00:12:00) Management Expectations vs. Reality""(00:16:00) Organizational Bottlenecks and Barriers""(00:18:00) The Need for AI Champions""(00:19:00) What the Community Wants Next""(00:22:00) Governance and Ethics Considerations""(00:23:00) Personas, Sales Enablement, and Search""(00:26:00) Strategic vs. Tactical AI Implementation""(00:30:00) Closing Advice from the Research Team""(00:33:00) Key Takeaways and Webinar Announcement"Join us for an in depth webinar covering the AI Cohort Research on October 8th at 1 pm ET.If you are interested in discussing this or any other topic, let's have a chat.  Reach out to me directly to schedule a no-obligation discussion. This isn't a sales call, but rather an opportunity to talk through your questions and challenges.Follow me on LinkedIn.Subscribe to The HealthTech Marketing Show on Spotify or watch us on YouTube for more insights into marketing, AI, ABM, buyer journeys, and beyond!Thank you to our presenting sponsors, HIMSS, a leader in advancing health equity, digital innovation, and data-driven care through technology, policy, and community collaboration. And also HealthcareNOW, 24/7 expert shows, interviews, and podcasts, powering healthcare leaders with innovation, policy, and strategy insights.

Welcome to the latest episode of L.I.F.T.S – your bite-sized dose of the Latest Industry Fitness Trends and Stories. This week, Matthew Januszek and Mohammed Iqbal sit down with Marco Benitez—former Taekwondo champion turned biomedical engineer and now CEO of rook, a health tech company that transforms wearable data into actionable health insights. Together, they explore how wearables are reshaping the future of fitness, healthcare, and personal health. Key topics covered include: Why your smartwatch might already know more about your health than your doctor. How Apple, Samsung, and Aura are competing in the wearable health space. The challenge of making sense of endless health data. What FDA approval for consumer wearables really means. How fitness coaches and gyms can use wearable data to improve client outcomes. The differences in HRV tracking across Apple, Whoop, and Aura. Wearables as a bridge between fitness and healthcare industries. The future of implants, rings, and continuous monitoring devices. Marco's vision for rook as the middleware connecting all wearable platforms.

AI Quick Take – Digital Twinning On this episode host Adam Turinas looks at one of the most fascinating yet misunderstood applications of AI in healthcare: digital twins. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen/

SomX's Jessica Somauroo and Belle Taylor dive into this week's healthtech news with help from Whereby's Niki Loboda and Hannah Jelliman00:00 - Intro02:44 - The State of Virtual Care33:43 - World's Top HealthTech Companies of 2025

Some founders win support because of their product, others because of their story. In healthcare, where trust is everything, the ability to tell a compelling and authentic narrative can make or break a company.On this episode, Halle talks with longtime friend and colleague Christina Farr—reporter turned investor and now author of The Storyteller's Advantage. Chrissy has spent thousands of hours hearing startup pitches, advising founders, and studying what makes certain stories resonate while others fall flat. She shares insights from her years as a journalist and investor, and lessons from her new book on how narrative power shapes companies and industries.We cover:

In this episode of Pulse, we launch our new alternating format with a deep-dive interview. Louise and George are joined by Dr Charlotte Blease, Associate Professor in Health Informatics at Uppsala University and researcher in Digital Psychiatry at Harvard Medical School, to discuss her newly released book Dr Bot: Why Doctors Can Fail Us and How AI Could Save Lives.Charlotte argues that our very humanness—the biases, blind spots, and emotional complexities of both clinicians and patients—can undermine the delivery of healthcare. Through a mix of anthropology, psychology, and digital health insight, she explores how AI could play a role in improving consultations, reducing information asymmetry, and supporting both patients and clinicians in making better decisions.Together, we cover:Why Charlotte wrote Dr Bot and why it matters nowHow our nature as humans shapes (and sometimes limits) care deliveryThe role of technology in empathy, bias, and knowledge managementPatients' stories, from everyday encounters to high-profile examples like Lisa Marie Presley and Serena WilliamsWhether we can truly remodel healthcare around the patientThe promises and pitfalls of big tech, surveillance capitalism, and regulation in healthHow AI could shift the culture of medicine, super-charge research, and reimagine the future of healthcareWhether you're a clinician, innovator, or simply curious about the intersection of medicine and technology, this conversation will get you thinking about the future of care.Resources:Dr Bot: Why Doctors Can Fail Us and How AI Could Save Lives – available now, releasing in Australia on 11 October (pre-order available)Follow Dr Charlotte Blease on LinkedInTo win a copy of Dr Bot: rate and review the pod in your app of choice, send us a screenshot at pulsepod@pulseit.newsVisit Pulse+IT.news to subscribe to breaking digital news, weekly newsletters and a rich treasure trove of archival material. People in the know, get their news from Pulse+IT – Your leading voice in digital health news.Follow us on LinkedIn Louise | George | Pulse+ITFollow us on BlueSky Louise | George | Pulse+ITSend us your questions pulsepod@pulseit.newsProduction by Octopod Productions | Ivan Juric

In this episode of Medsider Radio, we sat down with Ahmed Elmouelhi, CEO of TRiCares.  TRiCares is developing Topaz, the first purpose-built transcatheter tricuspid valve replacement system — a technology designed specifically for the right side of the heart, where complex anatomy has made durable solutions elusive.Ahmed is a 20-year medtech veteran with leadership experience across electrophysiology, men's health, neuromodulation, and structural heart. Before joining TRiCares, he helped build multiple businesses at AtriCure and held key roles at Medtronic during the early days of TAVR. He also serves as Chairman of the American Heart Association in Minnesota.In this interview, Ahmed shares why adoption — not added complexity — is the ultimate measure of medtech innovation, how a small group of physician champions can accelerate clinical studies faster than internal resources alone, and why treating your board like collaborators in the “sandbox” leads to stronger partnerships and better outcomes.Before we dive into the discussion, I wanted to mention a few things:First, if you're into learning from medical device and health technology founders and CEOs, and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.Second, if you want to peek behind the curtain of the world's most successful startups, you should consider a Medsider premium membership. You'll learn the strategies and tactics that founders and CEOs use to build and grow companies like Silk Road Medical, AliveCor, Shockwave Medical, and hundreds more!We recently introduced some fantastic additions exclusively for Medsider premium members, including playbooks, which are curated collections of our top Medsider interviews on key topics like capital fundraising and risk mitigation, and 3 packages that will help you make use of our database of 750+ life science investors more efficiently for your fundraise and help you discover your next medical device or health technology investor!In addition to the entire back catalog of Medsider interviews over the past decade, premium members also get a copy of every volume of Medsider Mentors at no additional cost, including the latest Medsider Mentors Volume VII. If you're interested, go to medsider.com/subscribe to learn more.Lastly, if you'd rather read than listen, here's a link to the full interview with Ahmed Elmouelhi.

Thanks to improved accuracy and new form factors, wearables have evolved from novelty step counters to tools that can predict illness, nudge healthier behaviors, and even influence alcohol consumption. But can they really bridge the gap between consumer wellness and enterprise healthcare?In this episode, ŌURA CEO Tom Hale discusses the lessons his team has learned from developing one of the most widely used health-tracking devices. We explore what draws people to wearables, what sustains their engagement, and how these tools may be shaping behavior and healthcare itself. We cover:

AI Quick Take: Mastering Prompt Engineering On this episode host Adam Turinas explores the critical concept of prompt engineering. This skill is fundamental in transforming how you use AI tools like ChatGPT, Claude, and Perplexity in your professional work. Most people are using these robust AI systems like glorified search engines, but to unlock their full potential for marketing, sales enablement, and content creation, mastering prompt engineering is essential. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen/

In this episode of Investor Connect, Hall Martin welcomes Uli Chettiapally, a distinguished physician, researcher, and healthcare innovator from Burlingame in the San Francisco Bay Area. Chettiapally shares his journey and expertise in driving physician-led innovation and collaboration through his firm, Innovator MD. He discusses how frontline medical professionals can identify unmet clinical needs and develop scalable solutions with the support of specialized education and networking opportunities provided by Innovator MD.  The conversation delves into the challenges and opportunities in funding healthcare startups, the role of AI and data in improving patient outcomes, and the importance of involving physicians early in the innovation process for realistic and effective healthcare solutions. Chettiapally also highlights his new venture, Sirica Therapeutics, aimed at revolutionizing autism treatment, and urges listeners to connect with him on LinkedIn for further collaborations.   Visit InnovatorMD & Sirica Therapeutics at   Reach out to at     _______________________________________________________ For more episodes from Investor Connect, please visit the site at:    Check out our other podcasts here:   For Investors check out:   For Startups check out:   For eGuides check out:   For upcoming Events, check out    For Feedback please contact info@tencapital.group    Please , share, and leave a review. Music courtesy of .

Interview: Dr Eric Topol (Part 2) In the second half of our conversation, Dr Eric Topol discusses AI's promise in reducing clinician burnout, forecasting disease, and reshaping prevention. He also reflects on 13 years since The Creative Destruction of Medicine, shares his favourite transformative tools, and offers advice for clinicians seeking creative careersAustralian CDC – the data angle Australia is finally moving ahead with its own Centre for Disease Control, promising better national coordination and public health data sharing. But will it deliver transparency and timely insights—or just more bureaucracy?AI & Fertility – SpermSearchAI delivers first UAE pregnancy An AI tool developed in Australia, by NeoGenix Biosciences, has achieved its first pregnancy in the UAE. The technology speeds up and improves IVF outcomes, showing how Australian health innovation is going global.US Information Blocking Enforcement The US Department of Health and Human Services will finally enforce penalties for health providers and IT vendors who block patient access to their own records. A big step for patient rights, and a reminder of how far Australia still has to go.Apple's Health Tech Push Apple's new Watch Series 11 now measures blood pressure and the latest AirPods can track heart rate. These updates blur the line between wellness gadgets and medical devices, raising big questions about accuracy, equity, and data overload.Eli Lilly's AI Drug Discovery Giveaway Pharma giant Eli Lilly is making its drug discovery language models publicly available through “Lilly TuneLab.” It's part open-science, part strategic play—accelerating research while still funnelling insights back to Lilly.Australian Robotics – Abi the Care Robot Melbourne startup Andromeda has raised $23m to scale Abi, a friendly robot designed for aged care and children's hospitals. Founder Grace Brown, just 25, has quickly become one of Australia's standout young innovators.Resources:Dr Eric Topol's book SuperAgers LinkDr Eric Topol's podcast & substack Ground Truths LinkMedicine and the Machine podcast with Dr Abraham Verghese and Dr Eric Topol LinkBook recommendation: The AI Valley, Gary Rivlin LinkRecommended FREE course: AI in Healthcare from RCSI LinkRecommended FREE course: Patient Insights Masterclass by Savvy Corporate LinkVisit Pulse+IT.news to subscribe to breaking digital news, weekly newsletters and a rich treasure trove of archival material. People in the know, get their news from Pulse+IT – Your leading voice in digital health news.Follow us on LinkedIn Louise | George | Pulse+ITFollow us on BlueSky Louise | George | Pulse+ITSend us your questions pulsepod@pulseit.newsProduction by Octopod Productions | Ivan Juric

In this episode of Medsider Radio, we sat down with Marc Penna, CEO of Voyager Biomedical. Voyager is a clinical-stage company tackling one of the most persistent challenges in dialysis care: reliable vascular access. Marc has more than 20 years of experience leading clinical research and regulatory programs across cardiology, vascular disease, and oncology. Since 2014, he has focused on early-stage ventures, with leadership roles at Intact Vascular and Vesper Medical — both acquired by Philips — as well as senior positions at Edwards Lifesciences, Boston Scientific, and AngioDynamics.In this interview, Marc shares how to pressure-test new medtech ideas, why collaboration with regulators and trial sites builds lasting credibility, and how disciplined fundraising and smart exit planning can set startups apart.Before we dive into the discussion, I wanted to mention a few things:First, if you're into learning from medical device and health technology founders and CEOs, and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.Second, if you want to peek behind the curtain of the world's most successful startups, you should consider a Medsider premium membership. You'll learn the strategies and tactics that founders and CEOs use to build and grow companies like Silk Road Medical, AliveCor, Shockwave Medical, and hundreds more!We recently introduced some fantastic additions exclusively for Medsider premium members, including playbooks, which are curated collections of our top Medsider interviews on key topics like capital fundraising and risk mitigation, and 3 packages that will help you make use of our database of 750+ life science investors more efficiently for your fundraise and help you discover your next medical device or health technology investor!In addition to the entire back catalog of Medsider interviews over the past decade, premium members also get a copy of every volume of Medsider Mentors at no additional cost, including the latest Medsider Mentors Volume VII. If you're interested, go to medsider.com/subscribe to learn more.Lastly, if you'd rather read than listen, here's a link to the full interview with Marc Penna.

AI accelerates drug discovery while steroids turn teens into aggressive strangers. Dr. Michael Israetel explores our pharmaceutical crossroads here!Full show notes and resources can be found here: jordanharbinger.com/1209What We Discuss with Michael Israetel:GLP-1 drugs like Tirzepatide offer massive health benefits beyond weight loss — reducing inflammation, improving brain health, and decreasing addiction behaviors, even for people already in good shape.Steroids don't just amplify personality — they specifically amplify masculine traits like aggression and reduce empathy. Starting young can permanently rewire your brain's emotional and social processing.AI is about to revolutionize medicine by testing millions of drug candidates virtually, creating treatments 10x more effective with 10x fewer side effects. We're entering the pharmaceutical iPhone moment.The "only take drugs when sick" mindset worked in the 20th century, but is becoming dangerously outdated — like refusing elevators because you prefer human operators.When your diet plateaus, take a week-long break eating at maintenance. Your stress hormones will drop, body water will flush out, and you'll often look leaner than before.And much more...And if you're still game to support us, please leave a review here — even one sentence helps! Sign up for Six-Minute Networking — our free networking and relationship development mini course — at jordanharbinger.com/course!Subscribe to our once-a-week Wee Bit Wiser newsletter today and start filling your Wednesdays with wisdom!Do you even Reddit, bro? Join us at r/JordanHarbinger!This Episode Is Brought To You By Our Fine Sponsors:Saily: 15% off: saily.com/jordanharbinger, code JORDANHARBINGERDripDrop: 20% off: DripDrop.com, code JORDANLinkedIn Jobs: Post your job for free: linkedin.com/jordanQuince: Free shipping & 365-day returns: quince.com/jordanBetterHelp: 10% off first month: betterhelp.com/jordanSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

AI companies are hitting growth milestones in record time—some reaching $100 million in revenue in just two years. But while this pace feels familiar in tech, healthcare has always been slower to adopt new tools. That may finally be changing.Kent Bennett and Sofia Guerra of Bessemer Venture Partners join Steve Kraus to unpack findings from Bessemer's State of AI 2025 report and what they mean for healthcare. From “supernovas” and “shooting stars” to the rise of systems of action, they explore how AI is reshaping not only software businesses but also the way doctors, health systems, and patients interact with technology.We cover:

Welcome to a fascinating exploration of the hidden legal battles shaping tomorrow's technology. Predictive algorithms have become the crystal balls of modern business, forecasting everything from home prices to healthcare costs, but they're also becoming the center of high-stakes courtroom dramas worth hundreds of millions of dollars.Across the globe, from Texas courtrooms to China's Supreme People's Court, judges and juries are answering a profound question: who owns the right to predict the future? The House Canary v. Amrock case resulted in a staggering $600 million verdict over real estate valuation algorithms, while Alibaba secured a 30 million RMB judgment against a company that allegedly scraped its predictive marketing tools. Even industrial applications aren't immune, with companies like Shen Group successfully protecting predictive design software for machinery components.What makes these cases particularly compelling is how they're redefining intellectual property law. Courts are now recognizing that AI model weights, the mathematical parameters tuned during training, qualify as protectable trade secrets. Data pipelines, prediction engines, and algorithmic structures have all received similar protection. The real drama often unfolds when employees change companies, raising thorny questions about what constitutes general expertise versus proprietary knowledge that belongs to the former employer.Healthcare prediction presents especially valuable territory, with ongoing battles between companies like Qruis and Epic Systems, or Milliman and Gradient AI, demonstrating how patient data forecasting creates immensely valuable intellectual property. Whether it's forecasting home values on Zillow or optimizing Medicare billing, these predictive tools aren't just convenient features, they're corporate crown jewels worth protecting at almost any cost.Ready to dive deeper into the invisible rules governing innovation? Subscribe now and join us as we continue to decode the legal frameworks shaping our technological future. The algorithms may predict tomorrow, but who gets to own those predictions? That's what we're exploring on Intangiblia.Get the book!Send us a textSupport the show

LinkedIn WTF?! On this episode host Adam Turinas discusses the significant decline in organic reach and engagement on LinkedIn. They has been instrumental in building Health Launchpad‘s brand over the years, but like many others, noticed it's simply not working the way it used to. Adam also reviews Richard Vander Blom's comprehensive LinkedIn Algorithm Report. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen/

The panel continues its discussion of Apple's latest announcements from the “Awe Dropping” event, focusing on the Apple Watch Series 11, new health and sleep tracking features, and the Ultra's extended battery life. Chuck Joiner, David Ginsburg, Marty Jencius, Brian Flanigan-Arthurs, Jim Rea, Web Bixby, Eric Bolden, and Mark Fuccio switch to the iPhone lineup, with debate over the new iPhone Air, Pro, and Pro Max models, camera improvements, storage options, and durability upgrades. The group weighs trade-in values, upgrade decisions, and how new features fit real-world use.  This edition of MacVoices is brought to you by our Patreon supporters. Get access to the MacVoices Slack and MacVoices After Dark by joining in at Patreon.com/macvoices. Show Notes: Chapters: [0:00] Apple Watch Series 11 First Impressions [1:33] Comfort and Bands for Sleep Tracking [2:21] Upgrade Decisions: Series 9 to Series 11 [4:55] Battery Life Improvements on Watch Models [5:44] Transition to iPhone Discussion [7:05] Sleep Score: New Health Tracking Feature [10:45] Health Tech, Insurance, and Oura Rings [12:41] First Reactions to iPhone Air and Pro Models [14:32] Considering Durability and Use Cases [16:51] Pro Max Loyalty and Color Choices [18:31] Video, Storage, and ProRes Capture [22:40] Heating Issues and A19 Pro Chip [24:07] iPhone Air Display Brightness and Modem Chips [25:48] Zoom Capabilities and AI Cropping Debate [28:52] Camera Stabilization and Sensor-Shifting [34:20] 3000-Nit Displays and 2TB Storage Options [35:18] Ceramic Back, Unibody Design, and Closing Thoughts Links: Apple's ‘Awe Dropping' Event - Recording Guests: Web Bixby has been in the insurance business for 40 years and has been an Apple user for longer than that.You can catch up with him on Facebook, Twitter, and LinkedIn, but prefers Bluesky. Eric Bolden is into macOS, plants, sci-fi, food, and is a rural internet supporter. You can connect with him on Twitter, by email at embolden@mac.com, on Mastodon at @eabolden@techhub.social, on his blog, Trending At Work, and as co-host on The Vision ProFiles podcast. Brian Flanigan-Arthurs is an educator with a passion for providing results-driven, innovative learning strategies for all students, but particularly those who are at-risk. He is also a tech enthusiast who has a particular affinity for Apple since he first used the Apple IIGS as a student. You can contact Brian on twitter as @brian8944. He also recently opened a Mastodon account at @brian8944@mastodon.cloud. Mark Fuccio is actively involved in high tech startup companies, both as a principle at piqsure.com, or as a marketing advisor through his consulting practice Tactics Sells High Tech, Inc. Mark was a proud investor in Microsoft from the mid-1990's selling in mid 2000, and hopes one day that MSFT will be again an attractive investment. You can contact Mark through Twitter, LinkedIn, or on Mastodon. David Ginsburg is the host of the weekly podcast In Touch With iOS where he discusses all things iOS, iPhone, iPad, Apple TV, Apple Watch, and related technologies. He is an IT professional supporting Mac, iOS and Windows users. Visit his YouTube channel at https://youtube.com/daveg65 and find and follow him on Twitter @daveg65 and on Mastodon at @daveg65@mastodon.cloud. Dr. Marty Jencius has been an Associate Professor of Counseling at Kent State University since 2000. He has over 120 publications in books, chapters, journal articles, and others, along with 200 podcasts related to counseling, counselor education, and faculty life. His technology interest led him to develop the counseling profession ‘firsts,' including listservs, a web-based peer-reviewed journal, The Journal of Technology in Counseling, teaching and conferencing in virtual worlds as the founder of Counselor Education in Second Life, and podcast founder/producer of CounselorAudioSource.net and ThePodTalk.net. Currently, he produces a podcast about counseling and life questions, the Circular Firing Squad, and digital video interviews with legacies capturing the history of the counseling field. This is also co-host of The Vision ProFiles podcast. Generally, Marty is chasing the newest tech trends, which explains his interest in A.I. for teaching, research, and productivity. Marty is an active presenter and past president of the NorthEast Ohio Apple Corp (NEOAC). Jim Rea built his own computer from scratch in 1975, started programming in 1977, and has been an independent Mac developer continuously since 1984. He is the founder of ProVUE Development, and the author of Panorama X, ProVUE's ultra fast RAM based database software for the macOS platform. He's been a speaker at MacTech, MacWorld Expo and other industry conferences. Follow Jim at provue.com and via @provuejim@techhub.social on Mastodon. Support: Become a MacVoices Patron on Patreon      http://patreon.com/macvoices      Enjoy this episode? Make a one-time donation with PayPal Connect: Web:      http://macvoices.com Twitter: http://www.twitter.com/chuckjoiner      http://www.twitter.com/macvoices Mastodon:      https://mastodon.cloud/@chuckjoiner Facebook:      http://www.facebook.com/chuck.joiner MacVoices Page on Facebook:      http://www.facebook.com/macvoices/ MacVoices Group on Facebook:      http://www.facebook.com/groups/macvoice LinkedIn:      https://www.linkedin.com/in/chuckjoiner/ Instagram:      https://www.instagram.com/chuckjoiner/ Subscribe:      Audio in iTunes      Video in iTunes      Subscribe manually via iTunes or any podcatcher: Audio: http://www.macvoices.com/rss/macvoicesrss      Video: http://www.macvoices.com/rss/macvoicesvideorss

The panel continues its discussion of Apple's latest announcements from the “Awe Dropping” event, focusing on the Apple Watch Series 11, new health and sleep tracking features, and the Ultra's extended battery life. Chuck Joiner, David Ginsburg, Marty Jencius, Brian Flanigan-Arthurs, Jim Rea, Web Bixby, Eric Bolden, and Mark Fuccio switch to the iPhone lineup, with debate over the new iPhone Air, Pro, and Pro Max models, camera improvements, storage options, and durability upgrades. The group weighs trade-in values, upgrade decisions, and how new features fit real-world use.  This edition of MacVoices is brought to you by our Patreon supporters. Get access to the MacVoices Slack and MacVoices After Dark by joining in at Patreon.com/macvoices. Show Notes: Chapters: [0:00] Apple Watch Series 11 First Impressions [1:33] Comfort and Bands for Sleep Tracking [2:21] Upgrade Decisions: Series 9 to Series 11 [4:55] Battery Life Improvements on Watch Models [5:44] Transition to iPhone Discussion [7:05] Sleep Score: New Health Tracking Feature [10:45] Health Tech, Insurance, and Oura Rings [12:41] First Reactions to iPhone Air and Pro Models [14:32] Considering Durability and Use Cases [16:51] Pro Max Loyalty and Color Choices [18:31] Video, Storage, and ProRes Capture [22:40] Heating Issues and A19 Pro Chip [24:07] iPhone Air Display Brightness and Modem Chips [25:48] Zoom Capabilities and AI Cropping Debate [28:52] Camera Stabilization and Sensor-Shifting [34:20] 3000-Nit Displays and 2TB Storage Options [35:18] Ceramic Back, Unibody Design, and Closing Thoughts Links: Apple's ‘Awe Dropping' Event - Recording Guests: Web Bixby has been in the insurance business for 40 years and has been an Apple user for longer than that.You can catch up with him on Facebook, Twitter, and LinkedIn, but prefers Bluesky. Eric Bolden is into macOS, plants, sci-fi, food, and is a rural internet supporter. You can connect with him on Twitter, by email at embolden@mac.com, on Mastodon at @eabolden@techhub.social, on his blog, Trending At Work, and as co-host on The Vision ProFiles podcast. Brian Flanigan-Arthurs is an educator with a passion for providing results-driven, innovative learning strategies for all students, but particularly those who are at-risk. He is also a tech enthusiast who has a particular affinity for Apple since he first used the Apple IIGS as a student. You can contact Brian on twitter as @brian8944. He also recently opened a Mastodon account at @brian8944@mastodon.cloud. Mark Fuccio is actively involved in high tech startup companies, both as a principle at piqsure.com, or as a marketing advisor through his consulting practice Tactics Sells High Tech, Inc. Mark was a proud investor in Microsoft from the mid-1990's selling in mid 2000, and hopes one day that MSFT will be again an attractive investment. You can contact Mark through Twitter, LinkedIn, or on Mastodon. David Ginsburg is the host of the weekly podcast In Touch With iOS where he discusses all things iOS, iPhone, iPad, Apple TV, Apple Watch, and related technologies. He is an IT professional supporting Mac, iOS and Windows users. Visit his YouTube channel at https://youtube.com/daveg65 and find and follow him on Twitter @daveg65 and on Mastodon at @daveg65@mastodon.cloud. Dr. Marty Jencius has been an Associate Professor of Counseling at Kent State University since 2000. He has over 120 publications in books, chapters, journal articles, and others, along with 200 podcasts related to counseling, counselor education, and faculty life. His technology interest led him to develop the counseling profession ‘firsts,' including listservs, a web-based peer-reviewed journal, The Journal of Technology in Counseling, teaching and conferencing in virtual worlds as the founder of Counselor Education in Second Life, and podcast founder/producer of CounselorAudioSource.net and ThePodTalk.net. Currently, he produces a podcast about counseling and life questions, the Circular Firing Squad, and digital video interviews with legacies capturing the history of the counseling field. This is also co-host of The Vision ProFiles podcast. Generally, Marty is chasing the newest tech trends, which explains his interest in A.I. for teaching, research, and productivity. Marty is an active presenter and past president of the NorthEast Ohio Apple Corp (NEOAC). Jim Rea built his own computer from scratch in 1975, started programming in 1977, and has been an independent Mac developer continuously since 1984. He is the founder of ProVUE Development, and the author of Panorama X, ProVUE's ultra fast RAM based database software for the macOS platform. He's been a speaker at MacTech, MacWorld Expo and other industry conferences. Follow Jim at provue.com and via @provuejim@techhub.social on Mastodon. Support:      Become a MacVoices Patron on Patreon      http://patreon.com/macvoices      Enjoy this episode? Make a one-time donation with PayPal Connect:      Web:      http://macvoices.com      Twitter:      http://www.twitter.com/chuckjoiner      http://www.twitter.com/macvoices      Mastodon:      https://mastodon.cloud/@chuckjoiner      Facebook:      http://www.facebook.com/chuck.joiner      MacVoices Page on Facebook:      http://www.facebook.com/macvoices/      MacVoices Group on Facebook:      http://www.facebook.com/groups/macvoice      LinkedIn:      https://www.linkedin.com/in/chuckjoiner/      Instagram:      https://www.instagram.com/chuckjoiner/ Subscribe:      Audio in iTunes      Video in iTunes      Subscribe manually via iTunes or any podcatcher:      Audio: http://www.macvoices.com/rss/macvoicesrss      Video: http://www.macvoices.com/rss/macvoicesvideorss

Episode 64 - Wendy Powell, founder of MUTU System, delivers a clinically validated digital pelvic health solution adopted by the NHS and US insurers, blending clinical credibility with scalable, accessible care for women. Disclaimer: Please note that all information and content on the UK Health Radio Network, all its radio broadcasts and podcasts are provided by the authors, producers, presenters and companies themselves and is only intended as additional information to your general knowledge. As a service to our listeners/readers our programs/content are for general information and entertainment only.  The UK Health Radio Network does not recommend, endorse, or object to the views, products or topics expressed or discussed by show hosts or their guests, authors and interviewees.  We suggest you always consult with your own professional – personal, medical, financial or legal advisor. So please do not delay or disregard any professional – personal, medical, financial or legal advice received due to something you have heard or read on the UK Health Radio Network.

Healthcare's “back-to-school” season delivered no shortage of big headlines! From Epic's big leap into AI to a looming insurance “blood bath,” Steve and Michael break down the stories that shaped digital health this month.We cover:

In this episode, Duane Mancini sits down with Walter Haydock, founder of StackAware and former Marine Corps intelligence officer, to explore the intersection of AI, cybersecurity, and startup leadership in the healthcare and life sciences sectors. Walter shares how his military background informs his approach to risk, decision-making, and company building, and offers practical strategies for navigating regulatory challenges, implementing effective AI governance, and avoiding common pitfalls as a healthtech founder. Walter Haydock LinkedInStackAware WebsiteDuane Mancini LinkedInProject Medtech WebsiteProject Medtech LinkedIn

AI Quick Take: Model Mania On this episode host Adam Turinas attempts to demystify the confusing landscape of AI models that's been a little overwhelming. The AI world feels like the mid-'90s browser wars all on steroids, with multiple companies vying for dominance, each with its own approach and philosophy. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen/

In this episode of Investor Connect, Hall Martin speaks with Rachna Dayal, a global health biotech and venture investment expert, founder of Sugati Ventures.  Rachna shares her transition from corporate roles at Johnson & Johnson and Philips to founding and running a venture fund focused on transformative health tech startups. She talks about the major differences between working in large corporations and managing a small VC fund, emphasizing the importance of flexibility and addressing high unmet needs in healthcare through innovative solutions in medical devices and AI-enabled platforms.  Rachna highlights her investment thesis around consumer-first, purpose-led brands, particularly focusing on life-saving devices and enhancing quality of life, and discusses the crucial role of founder-market fit and diverse backgrounds in fostering innovation in the healthcare space. She also touches on current trends such as the rise of AI in healthcare and the impact of economic conditions on venture capital, offering advice for new investors and emphasizing the need for perseverance during tough times in the investment landscape.  Visit Sugati Ventures at Reach out to at   _______________________________________________________ For more episodes from Investor Connect, please visit the site at:    Check out our other podcasts here:   For Investors check out:   For Startups check out:   For eGuides check out:   For upcoming Events, check out    For Feedback please contact info@tencapital.group    Please , share, and leave a review. Music courtesy of .

Interview: Dr Eric Topol (Part 1)We're joined by Dr Eric Topol—cardiologist, scientist, author, and global digital health leader. In part one, Eric shares his journey from clinician to digital health pioneer, his vision for “SuperAgers,” and why genomics and personalised medicine could redefine how long—and how well—we liveChatbots for PatientsWe discuss the Wall Street Journal's bold claim that chatbots could become part of the medical team. From spotting errors to translating lab results and reminding patients about medications, can they really serve as low-risk, always-on companion? Questions remain around accuracy, empathy, and whether they truly add value or just more noise.The Human Side of InteroperabilityInspired by Amy Gleason's LA Times op-ed, we look at the personal impact of fragmented health systems. Her daughter's care journey shows how disconnected records hinder outcomes—and how AI uncovered a hidden opportunity. Should we lean into more personal stories to communicate to a wider audience?Meta & Who Owns Your Health Data?A San Francisco jury found Meta guilty of illegally harvesting data from millions of Flo app users—menstrual cycles, ovulation, even pregnancy intentions. The ruling highlights urgent questions: Who really owns health data, and what rights do patients have when tech giants treat it like ad fuel?Patient Consent in the Age of AIConsent forms are broken—static, outdated, and unfit for the AI era. We unpack Y. Tony Yang's American Journal of Bioethics piece arguing for “dynamic consent,” accountability frameworks, and real patient understanding. Without rethinking consent, healthcare risks losing trust as AI tools grow more influentialBlack Box for Aged CareWhat if aged care had a “black box,” like aviation? Sensors, AI, and monitoring systems could flag risks before crises hit. A Pulse+IT blog argues for shifting from reactive to proactive care, but business models and adoption lag behind. We debate whether the sector can finally move from inquiry to preventionResources:Louise's LinkedIn poll on gen AI use for health research LinkDr Eric Topol's book SuperAgers LinkY. Tony Yang's American Journal of Bioethics Article on Patient Consent LinkAged Care's Black Box in Pulse+IT LinkAmy Gleason's parental perspective on the need for health data interoperability LinkVisit Pulse+IT.news to subscribe to breaking digital news, weekly newsletters and a rich treasure trove of archival material. People in the know, get their news from Pulse+IT – Your leading voice in digital health news.

Rohit Nuwal is a Partner at TELUS Global Ventures, Canada's largest and most active corporate venture capital fund, with over 100 investments across transformative sectors such as HealthTech, AgTech, IoT, and AI. In this episode, we explore TELUS' unique approach to commercialization beyond capital — and how they leverage deep insights from their global businesses to provide investment partners with a pathway to real-world traction and growth. Rohit shares how their Strategic Portfolio Development team, combined with a distinctive incentive structure within the core business, accelerates adoption — generating over $100M in P&L value.

In this episode of Medsider Radio, we sat down with Christopher Haig, co-founder and CEO of Efemoral Medical. Efemoral is developing bioresorbable scaffold technology for peripheral arterial disease. Chris has over 25 years of experience in cardiovascular devices, holding leadership roles at strategics including Guidant Corporation and Abbott Vascular, and driving growth at startups such as Calypso Medical and QT Vascular, where he built commercial infrastructure and launched multiple products ahead of its $55 million IPO.In this interview, Chris shares how bioresorbable scaffold technology found new life for peripheral arterial disease — and the lessons on matching tech to significant needs and choosing trial sites for lasting data.Before we dive into the discussion, I wanted to mention a few things:First, if you're into learning from medical device and health technology founders and CEOs, and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.Second, if you want to peek behind the curtain of the world's most successful startups, you should consider a Medsider premium membership. You'll learn the strategies and tactics that founders and CEOs use to build and grow companies like Silk Road Medical, AliveCor, Shockwave Medical, and hundreds more!We recently introduced some fantastic additions exclusively for Medsider premium members, including playbooks, which are curated collections of our top Medsider interviews on key topics like capital fundraising and risk mitigation, and 3 packages that will help you make use of our database of 750+ life science investors more efficiently for your fundraise and help you discover your next medical device or health technology investor!In addition to the entire back catalog of Medsider interviews over the past decade, premium members also get a copy of every volume of Medsider Mentors at no additional cost, including the latest Medsider Mentors Volume VII. If you're interested, go to medsider.com/subscribe to learn more.Lastly, if you'd rather read than listen, here's a link to the full interview with Christopher Haig.

Healthcare costs keep climbing, and yet patients and employers often feel powerless to change the system. What if outsiders—those not steeped in the traditions of healthcare—are actually the ones best positioned to fix it?This special episode is a reshare from The Benefits Playbook podcast, where Halle joins Collective Health CEO Ali Diab. Together, they unpack what it takes to make health benefits simpler, more transparent, and more consumer-focused.We cover:

Episode 63 - Devika Wood is the CEO of Brain+, a pioneering health technology company transforming dementia care through its digital platform, Ayla. Disclaimer: Please note that all information and content on the UK Health Radio Network, all its radio broadcasts and podcasts are provided by the authors, producers, presenters and companies themselves and is only intended as additional information to your general knowledge. As a service to our listeners/readers our programs/content are for general information and entertainment only.  The UK Health Radio Network does not recommend, endorse, or object to the views, products or topics expressed or discussed by show hosts or their guests, authors and interviewees.  We suggest you always consult with your own professional – personal, medical, financial or legal advisor. So please do not delay or disregard any professional – personal, medical, financial or legal advice received due to something you have heard or read on the UK Health Radio Network.

Send us a textLearn how you can scale your care team with AI: https://link.CareCo.ai/rmvhvqIn this episode I sit down with Steve Wardell, managing partner at Wardell Advisors LLC, for an eye-opening conversation that peels back the curtain on healthcare venture capital. Drawing parallels between HBO's Silicon Valley and the real digital health VC world, Wardell breaks down the psychology behind investor behavior, explains why playing "hard to get" with VCs can backfire, and reveals the red flags that signal toxic investor relationships. This episode is essential listening for health tech founders navigating today's funding landscape, where AI-enabled startups are capturing the majority of investment dollars and the "full stack" trend is revolutionizing how VCs think about healthcare companies. Wardell provides actionable insights on funding stages, market consolidation opportunities, and the strategic mistakes that waste entrepreneurs' time while sharing proven frameworks for positioning yourself as an expert rather than a supplicant when pitching to venture capital firms.Timestamps: 00:00:00 - Introduction and Welcome 00:05:58 - The Psychology of VC Funding 00:12:25 - Funding Stages Breakdown00:23:00 - Bootstrapping vs the VC Treadmill 00:25:32 - Red Flags and Toxic Investors 00:35:15 - How to Pitch VCs Effectively 00:41:42 - Specialized vs Generalist Funds 00:48:00 - Closing Thoughts

Creating a new Category in the Middle of the AI Revolution On this episode host Adam Turinas and his guest Kristin Russel, CMO of symplr unpacks how she's building a unified brand in one of the most complex corners of healthcare, and doing it right in the middle of the AI revolution. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen/

In this episode of Disruption/Interruption, host KJ sits down with Dhruv Vig, founder and CEO of Langer Holdings, to discuss how AI is revolutionizing health tech investing. Dhruv shares how legacy investment models are failing to capture the true potential of health tech, the pitfalls of misclassification in ETFs, and why active management and expert-driven curation are the future. Discover how curiosity and a drive to challenge the status quo can lead to industry-changing innovation. Key Takeaways: [1:46] - Legacy Indices Are Outdated"The way we invest in health tech is stuck in the past, legacy indices overlook game-changing companies." [10:44] - Misclassification and Underweighting Are Rampant"Companies are being misclassified, and the best performers are often underweighted in broad market funds." [15:02] - Active Management and Expert Curation Are Essential"You can't trust an algorithm to this. You have to have experts... to clean up the public markets and set the industry standard." [3:17] - Curiosity Drives Disruption"Insatiable curiosity... that's what drives me. I can't sit still. You gotta keep learning, gotta keep asking questions." Quote of the Show (27:07):"When you sit down and look at your portfolio, do the work. Really ask what am I investing in and why am I investing in it?” — Dhruv Vig Join our Anti-PR newsletter where we’re keeping a watchful and clever eye on PR trends, PR fails, and interesting news in tech so you don't have to. You're welcome. Want PR that actually matters? Get 30 minutes of expert advice in a fast-paced, zero-nonsense session from Karla Jo Helms, a veteran Crisis PR and Anti-PR Strategist who knows how to tell your story in the best possible light and get the exposure you need to disrupt your industry. Click here to book your call: https://info.jotopr.com/free-anti-pr-eval Ways to connect with Dhruv Vig: LinkedIn: https://www.linkedin.com/in/dhruvkvig/ Company website: https://langarfunds.com/ Company LinkedIn: https://www.linkedin.com/company/langar-holdings/ How to get more Disruption/Interruption: Amazon Music - https://music.amazon.com/podcasts/eccda84d-4d5b-4c52-ba54-7fd8af3cbe87/disruption-interruption Apple Podcast - https://podcasts.apple.com/us/podcast/disruption-interruption/id1581985755 Spotify - https://open.spotify.com/show/6yGSwcSp8J354awJkCmJlDSee omnystudio.com/listener for privacy information.

Episode 62 - Dan Vahdat is the founder and CEO of Huma, a healthcare AI company valued at over $1 billion, dedicated to accelerating the adoption of digital solutions in healthcare and research. Disclaimer: Please note that all information and content on the UK Health Radio Network, all its radio broadcasts and podcasts are provided by the authors, producers, presenters and companies themselves and is only intended as additional information to your general knowledge. As a service to our listeners/readers our programs/content are for general information and entertainment only.  The UK Health Radio Network does not recommend, endorse, or object to the views, products or topics expressed or discussed by show hosts or their guests, authors and interviewees.  We suggest you always consult with your own professional – personal, medical, financial or legal advisor. So please do not delay or disregard any professional – personal, medical, financial or legal advice received due to something you have heard or read on the UK Health Radio Network.

In this episode of Medsider Radio, we sat down with Howard Rosen, co-Founder and CEO of Evident Vascular, a company developing an AI-powered intravascular ultrasound (IVUS) platform to improve vascular imaging and intervention. Before co-founding Evident, Howard held senior leadership roles at Intact Vascular and Vesper Medical, guiding both companies through successful acquisitions by Philips. He also served in executive roles at Haemonetics and BG Medicine, and spent over two decades at Boston Scientific, where he held a range of leadership positions across the peripheral and cardiovascular franchises.In this interview, Howard shares why launching right — not fast — is the key to success in medtech. He breaks down how Evident built early momentum by investing in deep market validation, engaging KOLs as true collaborators, and resisting scope creep at every turn. Howard also unpacks the company's deliberate regulatory strategy, using early FDA engagement as a tool to de-risk development. On the fundraising front, he explains why board composition matters more than valuation, and why strategic acquirers respond best to credibility, not cold outreach.Before we dive into the discussion, I wanted to mention a few things:First, if you're into learning from medical device and health technology founders and CEOs, and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.Second, if you want to peek behind the curtain of the world's most successful startups, you should consider a Medsider premium membership. You'll learn the strategies and tactics that founders and CEOs use to build and grow companies like Silk Road Medical, AliveCor, Shockwave Medical, and hundreds more!We recently introduced some fantastic additions exclusively for Medsider premium members, including playbooks, which are curated collections of our top Medsider interviews on key topics like capital fundraising and risk mitigation, and 3 packages that will help you make use of our database of 750+ life science investors more efficiently for your fundraise and help you discover your next medical device or health technology investor!In addition to the entire back catalog of Medsider interviews over the past decade, premium members also get a copy of every volume of Medsider Mentors at no additional cost, including the latest Medsider Mentors Volume VII. If you're interested, go to medsider.com/subscribe to learn more.Lastly, if you'd rather read than listen, here's a link to the full interview with Howard Rosen.

Hospitals are under immense pressure: burned-out clinicians, outdated systems, and rising costs have made delivering care harder than ever. Tanay Tandon, founder and CEO of Commure, shares how his team is rethinking hospital infrastructure by combining AI, forward-deployed engineering, and a provider-first mindset. Backed by over $750M in funding, Commure is using strategic M&A and next-gen tools like ambient AI to reduce administrative burden, improve revenue cycle operations, and protect clinical staff.We cover:

AI Quick Take: ChatGPT Agent On this episode host Adam Turinas reviews one of the most intriguing recent developments in AI – OpenAI's introduction of ChatGPT Agent. He breaks down what makes ChatGPT Agent fundamentally different from the ChatGPT we are all familiar with. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen

Will more data solve AI hallucinations? Maybe. But what about the industries that have the most to gain (and lose) from AI transformation like healthcare? Join us as we dive deep into the role of data and transformation and what obstacles the healthcare industry still has to clear to turn their digital delusions into data dreams. Newsletter: Sign up for our free daily newsletterMore on this Episode: Episode PageJoin the discussion: Thoughts on this? Join the convo and connect with other AI leaders on LinkedIn.Upcoming Episodes: Check out the upcoming Everyday AI Livestream lineupWebsite: YourEverydayAI.comEmail The Show: info@youreverydayai.comConnect with Jordan on LinkedInTopics Covered in This Episode:Trillion-Dollar Data Center Investments for AIGenerative AI Transforming Health Tech Use CasesAI and Physician Burnout SolutionsOrganizational Challenges: AI Literacy and EducationData Quality, Cleanliness, and Health Tech OutcomesTransparency and Accountability in Health Data PipelinesImportance of RAG (Retrieval Augmented Generation)AI Hallucinations and Patient Safety RisksOpen Source AI Models and Health Data PrivacyFuture Impacts of Large Language Model InvestmentsTimestamps:00:00 "Tech and Healthcare Evolution Insights"06:50 AI Investment and Data Challenges in Ghana09:48 Ensuring Accurate, Real-Time Data Retrieval13:18 "Building Transparent GenAI Models"15:54 Prior Authorization Ensures Claims Accuracy18:34 Responsible Data Management Challenges22:45 AI Data Accuracy and Consequences25:04 Data Transparency and Accuracy ImperativeKeywords:Generative AI in health tech, artificial intelligence in healthcare, large language models, data center investment, AI hallucinations, data quality, retrieval augmented generation (RAG), physician burnout, AI-powered clinical notes, medical imaging AI, HR workforce optimization, health tech digital transformation, healthcare data privacy, healthcare data security, AI model training, AI education, data literacy, operational efficiency in healthcare, sustainable data centers, environmental impact of data centers, transparency in AI, data trustworthiness, real-time data extraction, cross-checking AI outputs, patient outcomes, healthcare regulations, high-stakes AI industries, open source AI models, AI supply chain management, healthcare claims denial, prior authorization automation, grounding AI models, human-in-the-loop in AI, data accuracy, precision in healthcare AI, medical decision making AISend Everyday AI and Jordan a text message. (We can't reply back unless you leave contact info)

In this episode of Medsider Radio, we sat down withTracy MacNeal, President and CEO of Materna Medical. Materna is developing two devices addressing different aspects of pelvic health: Ellora, aimed at preventing childbirth injuries during delivery, and Milli, designed to treat vaginismus, a pelvic floor condition that makes intercourse painful or impossible.Tracy is a healthcare executive and engineer with over 25 years of experience in medical devices, digital health, and women's health, including six successful transactions. In addition to heading Materna, Tracy serves on the AdvaMed Board and leads its Women's Health Equity Initiative, and was previously President of Diagnostics and Digital Health at Ximedica.In this interview, Tracy shares how clinical data enabled Materna to bridge B2B and B2C channels, and why clarity of focus is essential when commercialization paths diverge. Tracy also outlines what it takes to build in undefined markets, from aligning KOLs to publishing foundational definitions, and offers a candid perspective on what investors really want: clear financial returns, backed by a founder they trust to deliver when things go sideways.Before we dive into the discussion, I wanted to mention a few things:First, if you're into learning from medical device and health technology founders and CEOs, and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.Second, if you want to peek behind the curtain of the world's most successful startups, you should consider a Medsider premium membership. You'll learn the strategies and tactics that founders and CEOs use to build and grow companies like Silk Road Medical, AliveCor, Shockwave Medical, and hundreds more!We recently introduced some fantastic additions exclusively for Medsider premium members, including playbooks, which are curated collections of our top Medsider interviews on key topics like capital fundraising and risk mitigation, and 3 packages that will help you make use of our database of 750+ life science investors more efficiently for your fundraise and help you discover your next medical device or health technology investor!In addition to the entire back catalog of Medsider interviews over the past decade, premium members also get a copy of every volume of Medsider Mentors at no additional cost, including the latest Medsider Mentors Volume VII. If you're interested, go to medsider.com/subscribe to learn more.Lastly, if you'd rather read than listen, here's a link to the full interview with Tracy MacNeal.

One in four Americans is enrolled in Medicaid, yet the system designed to support them is constantly at risk—underfunded, politically vulnerable, and often overlooked.Dr. Alastair Bell, President and CEO of Boston Medical Center Health System, shares how his organization is reimagining what it means to care for underserved populations, while managing nearly 40% of Massachusetts' Medicaid enrollees. In this conversation, we explore the financial realities of running an “essential” hospital system, the opportunities and pitfalls of Medicaid ACOs, and why AI might deepen inequity if essential providers are left behind.We cover:

In this episode of The Healthy Project Podcast, host Corey Dion Lewis talks with Pamela Oren-Artzi, COO and co-founder of GRIN, a digital oral health platform reimagining how care is delivered for underserved communities. Pam shares her journey from technology leader to health innovator, the challenges of addressing oral care deserts, and how GRIN's accessible, affordable tools are transforming the way providers reach patients—no broadband required.We explore why oral health must be recognized as a core social driver of health, the connection between oral disease and chronic conditions like heart disease and diabetes, and the ripple effects that poor access to dental care can have on individuals, families, and the economy. Pam also offers valuable insights for health tech innovators on how to build equity into products from the ground up.

In today's episode, we sit down with Ron Richard, a respiratory, pulmonary, and sleep medicine expert who advocates for those in need while striving for impactful solutions. As the Founder of BLD Consulting, he is a seasoned expert specializing in the medical device, medical diagnostic, and life science market segments. What has he learned during his 35 years of experience in the medical industry? He joins us to explain… Hit play to find out: The primary focus of BLD Consulting and how they are shaping modern medical devices. The benefits of monitoring blood pressure and glucose with wearable technology. Cutting-edge advancements in medical equipment. Inside information on the future of remote monitoring. Ron is a recipient of several industry-based awards, has launched over 40 products, and holds 17 patents both nationally and internationally. He is also the author of Someday is TODAY!, a book that draws from his own experience to give readers guidelines on how to take an initial idea and develop it into a product – all while just sipping coffee. To learn more about Ron and his dedication to improving healthcare outcomes, visit the BLD Consulting today! Upgrade Your Wallet Game with Ekster!  Get the sleek, smart wallet you deserve—and save while you're at it! Use coupon code FINDINGGENIUS at checkout or shop now with this exclusive link: ekster.com?sca_ref=4822922.DtoeXHFUmQ5  Smarter, slimmer, better. Don't miss out! Episode also available on Apple Podcasts: apple.co/30PvU9C

Three simple questions plague every American seeking healthcare: Where should I go? When can I be seen? And how much will it cost me? Despite seeming basic, these questions have remained largely unanswerable—until now.In this episode, we explore how Heather Fernandez, co-founder and CEO of Solv, is building the infrastructure behind same-day care for 210 million Americans. We discuss how AI is finally cracking the code on price transparency and why workflow complexity can be a competitive moat in healthcare.We cover: